SE462420B - Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan - Google Patents

Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan

Info

Publication number
SE462420B
SE462420B SE8304818A SE8304818A SE462420B SE 462420 B SE462420 B SE 462420B SE 8304818 A SE8304818 A SE 8304818A SE 8304818 A SE8304818 A SE 8304818A SE 462420 B SE462420 B SE 462420B
Authority
SE
Sweden
Prior art keywords
effect
trans
acid
pyrrolidinyl
application
Prior art date
Application number
SE8304818A
Other languages
English (en)
Swedish (sv)
Other versions
SE8304818D0 (sv
SE8304818L (sv
Inventor
L Benes
A Babulova
V Nosalova
S Stolc
A Borovansky
V Bauer
Original Assignee
Slovenska Akademia Vied
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovenska Akademia Vied filed Critical Slovenska Akademia Vied
Publication of SE8304818D0 publication Critical patent/SE8304818D0/xx
Publication of SE8304818L publication Critical patent/SE8304818L/xx
Publication of SE462420B publication Critical patent/SE462420B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8304818A 1983-09-13 1983-09-08 Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan SE462420B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333008 DE3333008A1 (de) 1983-09-13 1983-09-13 Pharmazeutische mittel mit antiulceroeser, spasmolytischer und lokalanaesthetischer wirkung

Publications (3)

Publication Number Publication Date
SE8304818D0 SE8304818D0 (sv) 1983-09-08
SE8304818L SE8304818L (sv) 1985-03-09
SE462420B true SE462420B (sv) 1990-06-25

Family

ID=6208945

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304818A SE462420B (sv) 1983-09-13 1983-09-08 Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan

Country Status (6)

Country Link
JP (1) JPS6067421A (pt)
BE (1) BE897823A (pt)
CH (1) CH654743A5 (pt)
DE (1) DE3333008A1 (pt)
NL (1) NL8303098A (pt)
SE (1) SE462420B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103380A (en) 1998-06-03 2000-08-15 Cabot Corporation Particle having an attached halide group and methods of making the same

Also Published As

Publication number Publication date
JPH045003B2 (pt) 1992-01-30
DE3333008C2 (pt) 1990-06-21
CH654743A5 (en) 1986-03-14
NL8303098A (nl) 1985-04-01
SE8304818D0 (sv) 1983-09-08
BE897823A (fr) 1984-01-16
DE3333008A1 (de) 1985-03-21
SE8304818L (sv) 1985-03-09
JPS6067421A (ja) 1985-04-17

Similar Documents

Publication Publication Date Title
AU638493B2 (en) Preparations containing colestyramine for reducing lipid levels
JP5538386B2 (ja) フェルラ酸とマトリン類化合物を含有する薬物組成物及びその製造方法と用途
TW304167B (pt)
WO2021023099A1 (zh) 一种马钱子碱凝胶制剂及其制备方法
US4973596A (en) Method of administering a narcotic analgesic and dosage forms therefor
SE462420B (sv) Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan
JPH09500121A (ja) 痴呆症の治療のためのナブメトンまたは６−メトキシナフチル酢酸の使用
CN111789832B (zh) 右酮洛芬氨丁三醇凝胶贴膏及其制备方法
EP2606883A1 (en) Uses of n-Butylidenephthalide in Treating a Liver Injury and Improving Liver Function
JP6178058B2 (ja) 抗炎症及び／又は抗ヒスタミン剤組成物
CN112691102A (zh) 黄芩素在防治帕金森病/帕金森综合征抑郁症状中的应用
JP2010241834A (ja) 医薬組成物
CN106507666A9 (zh) 1，3‑丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途
JP2938579B2 (ja) 消化管壁保護剤
US4348407A (en) Orally active tolciclate and tolnaftate
CN105663152A (zh) 三乙酰基-3-羟基苯基腺苷在制备改善胰岛素抵抗及相关疾病中的应用
JP5389471B2 (ja) 鼻閉抑制剤
CN101264081B (zh) 治疗肺纤维化的化合物
JP2006008540A (ja) 風邪薬
CN113181178A (zh) 盐酸去亚甲基四氢小檗碱在制备预防或治疗疼痛药物中的应用
WO2019242764A1 (zh) 糖苷类化合物在制备防治糖尿病并发症的药物中的应用
BR202020007803U2 (pt) Sistema para administração de formulações orais em animais de médio e grande porte
CA3232946A1 (en) Pharmaceutical composition for preventing or treating alzheimer's disease
CN114903910A (zh) 芹菜素-7-O-β-D-葡萄糖苷在制备炎症性肠病治疗药物中的应用
CN118178301A (zh) 一种经口腔黏膜给药的羟基红花黄色素a组合物及其制备方法和应用

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304818-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8304818-1

Format of ref document f/p: F